XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common Stock
Additional Paid In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Dec. 31, 2018   3,845,361      
Beginning Balance at Dec. 31, 2018 $ 16,859,266 $ 3,846 $ 91,276,086 $ (74,420,666) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   80,000      
Exercise of stock options 601,250 $ 80 601,170    
Stock based compensation 1,065,852   1,065,852    
Net income (loss) (in thousands) (1,736,020)     (1,736,020)  
Ending Balance (in shares) at Mar. 31, 2019   3,925,361      
Ending Balance at Mar. 31, 2019 16,790,348 $ 3,926 92,943,108 (76,156,686) 0
Beginning Balance (in shares) at Dec. 31, 2018   3,845,361      
Beginning Balance at Dec. 31, 2018 16,859,266 $ 3,846 91,276,086 (74,420,666) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (in thousands) (157,847)        
Other comprehensive loss - foreign currency translation adjustment 0        
Ending Balance (in shares) at Jun. 30, 2019   4,025,500      
Ending Balance at Jun. 30, 2019 20,063,065 $ 4,026 94,637,552 (74,578,513) 0
Beginning Balance (in shares) at Mar. 31, 2019   3,925,361      
Beginning Balance at Mar. 31, 2019 16,790,348 $ 3,926 92,943,108 (76,156,686) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   100,139      
Exercise of stock options 833,890 $ 100 833,790    
Stock based compensation 860,654   860,654    
Net income (loss) (in thousands) 1,578,173     1,578,173  
Other comprehensive loss - foreign currency translation adjustment 0        
Ending Balance (in shares) at Jun. 30, 2019   4,025,500      
Ending Balance at Jun. 30, 2019 20,063,065 $ 4,026 94,637,552 (74,578,513) 0
Beginning Balance (in shares) at Dec. 31, 2019   4,186,438      
Beginning Balance at Dec. 31, 2019 34,416,026 $ 4,187 97,239,455 (62,827,616) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   12,157      
Exercise of stock options 90,000 $ 12 89,988    
Exercise of warrants (in shares)   59,510      
Exercise of warrants 595,101 $ 60 595,041    
Stock based compensation 686,599   686,599    
Net income (loss) (in thousands) (1,684,643)     (1,684,643)  
Other comprehensive loss - foreign currency translation adjustment (293,491)       (293,491)
Ending Balance (in shares) at Mar. 31, 2020   4,258,105      
Ending Balance at Mar. 31, 2020 33,809,592 $ 4,259 98,611,083 (64,512,259) (293,491)
Beginning Balance (in shares) at Dec. 31, 2019   4,186,438      
Beginning Balance at Dec. 31, 2019 34,416,026 $ 4,187 97,239,455 (62,827,616) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (in thousands) (1,900,848)        
Other comprehensive loss - foreign currency translation adjustment (310,720)        
Ending Balance (in shares) at Jun. 30, 2020   4,258,105      
Ending Balance at Jun. 30, 2020 34,296,258 $ 4,259 99,331,183 (64,728,464) (310,720)
Beginning Balance (in shares) at Mar. 31, 2020   4,258,105      
Beginning Balance at Mar. 31, 2020 33,809,592 $ 4,259 98,611,083 (64,512,259) (293,491)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock based compensation 720,100   720,100    
Net income (loss) (in thousands) (216,205)     (216,205)  
Other comprehensive loss - foreign currency translation adjustment (17,229)       (17,229)
Ending Balance (in shares) at Jun. 30, 2020   4,258,105      
Ending Balance at Jun. 30, 2020 $ 34,296,258 $ 4,259 $ 99,331,183 $ (64,728,464) $ (310,720)